MBC-11
MBC-11 is a first-in-class conjugate of the bone-targeting bisphosphonate etidronate covalently linked to the antimetabolite cytarabine (araC) . MBC-11 has the potential for tumor-induced bone disease (TIBD) research[1].
Product Specifications
CAS Number
332863-86-2
UNSPSC
12352005
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/MBC-11.html
Solubility
10 mM in DMSO
Smiles
CC(P(O)(O)=O)(P(O)(OP(O)(OC[C@@H]1[C@@H](O)[C@H](O)[C@H](N2C=CC(N)=NC2=O)O1)=O)=O)O
Molecular Formula
C11H20N3O14P3
Molecular Weight
511.21
References & Citations
[1]Reinholz MM, et al. A promising approach for treatment of tumor-induced bone diseases: utilizing bisphosphonate derivatives of nucleoside antimetabolites. Bone. 2010 Jul;47 (1) :12-22.|[2]Zinnen SP, et al. First-in-Human Phase I Study of MBC-11, a Novel Bone-Targeted Cytarabine-Etidronate Conjugate in Patients with Cancer-Induced Bone Disease. Oncologist. 2019 Mar;24 (3) :303-e102.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
QP5519-2ug 2ug
Recombinant Rat M-CSF/ CSF-1 Protein, Untagged, E.coli-2ug
Sign In for Pricing
View Details ![Mouse Monoclonal MGRN1 Antibody (OTI3C3) [DyLight 680]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
NBP2-72665FR 0.1 mL
Mouse Monoclonal MGRN1 Antibody (OTI3C3) [DyLight 680]
Sign In for Pricing
View Details bs-3750R-Biotin-TR 20 µL
BMAL1 Polyclonal Antibody, Biotin Conjugated
Sign In for Pricing
View Details